ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1238

Effects of Stress On Clinical Presentation of Patients with Early Rheumatoid Arthritis

Yun A. Kim1, Jane E. Salmon2, Juan Xiong3, Boulos Haraoui4, Carol A. Hitchon5, Edward Keystone6, Janet E. Pope7, Diane Tin8, J. Carter Thorne9, Gilles Boire10, Vivian P. Bykerk2 and CATCH11, 1Hospital for Special Surgery (and Kwangju Christian Hospital, Gwangju, Korea), New York, NY, 2Rheumatology, Hospital for Special Surgery, New York, NY, 3Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada, 4Osteoarthritis Research Unit, University of Montreal Hospital Research Centre (CRCHUM), Montreal, QC, Canada, 5University of Manitoba, Winnipeg, MB, Canada, 6University of Toronto, Toronto, ON, Canada, 7Medicine, Divsion of Rheumatology, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada, 8The Arthritis Program, Southlake Regional Health Centre, Newmarket, ON, Canada, 9Southlake Regional Health Centre, Newmarket, ON, Canada, 10Rheumatology Division, Centre Hospitalier Universitaire de Sherbrooke, Université de Sherbrooke, Sherbrooke, QC, Canada, 11Toronto

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Rheumatoid arthritis (RA) and stress

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Rheumatoid Arthritis - Clinical Aspects II: Clinical Features & Comorbidity/Cardiovascular Disease

Session Type: Abstract Submissions (ACR)

Background/Purpose: Stress is related to pathogenesis and progression of inflammatory autoimmune disorders. The aim of this study is to evaluate the role of patient (pt) self reported stress within a year of clinical presentation, particularly pt reported outcomes (PROs) in patients (pts) with early rheumatoid arthritis (ERA).

Methods: 951 pts in CATCH (Canadian Early Arthritis Cohort), a prospective multicentre observational cohort, who answered a modified stress & life events questionnaire, were included. Psychological (Psych) stress was defined as death of family member, divorce, separation, family stress and financial stress. Physical stress was defined as motor vehicle accident, surgery, major illness and infection. Differences in baseline characteristics and PROs in pts at 6 months and 1 year reporting exposure or not to stress were compared. Differences were compared using Chi-Square tests for categorical and Wilcoxon rank sum test for continuous variables.

Results: Mean age (SD) was 53.8(14.2). Mean symptom duration (SD) was 6.0 (3.1) months, 83% were Caucasian, 73% female and 18% smokers. Features distinguishing pts with exposure to either stress vs. none are noted in Table 1. More pts reporting psych stress were female, living alone, employed and fatigued (p<0.05). More pts reporting physical stress and were female, older, had a higher HAQ score, and more co-morbidities (p<0.05). Symptom duration, AM stiffness, smoking, race, education, income and marital status were not associated with stress. Pain, fatigue and HAQ scores were elevated at 0,6 and 12 months in patients exposed to stress vs. non-exposed though these improved to a similar degree in both groups. (Table2).

 Table 1. Patients reporting exposure to psychological or physical stress versus no stress

Variables

No stress

Psychological stress

 Physical stress

n=454

n=307

n=69

Age

54.2±15.0

53.0±12.49

58.5±12.8*

Female sex

318(70.0%)

239(77.9%)*

39(56.5%)*

Living alone, n (%)

51(11.4%)

54(17.7%)*

11(16.2%)

Employed, n (%)

238(52.4%)

191(62.2%)*

32(46.4%)

Pain (0-10mm)

5.4± 2.8

5.7± 2.7

5.5± 3.0

Fatigue (0-10mm)

4.8± 3.0

5.6± 2.9*

4.9± 2.7

DAS28 score

5.0± 1.5

5.0± 1.5

5.2± 1.6

HAQ score

0.96± 0.70

1.01± 0.66

1.14± 0.71*

Erosions, n (%)

100(27.4%)

72(28.0%)

18(32.1%)

Co-morbidities, n (%)

384(84.6%)

268(87.3%)

66(95.7%)*

*p-value < .05, Values are mean ± SD unless indicated

Table 2. Outcomes after 6 months and 1 year in patients exposed to stress versus no stress

Variables

6 month stress + (n=447)

6 month Stress – (n=392)

1year stress + (n=463)

1 year stress – (n=423)

Pain (0-10mm)

3.5±2.8*

3.0±2.6

3.0±2.6*

2.7±2.5

Fatigue (0-10mm)

3.7±3.0*

3.3±2.9

3.3±2.8*

2.9±2.7

DAS28 score

3.3±1.5

3.3±1.5

3.0±1.5

2.9±1.3

HAQ score

0.6±0.6*

0.5±0.6

0.5±0.6*

0.4±0.6

* p < .05, Values are mean ± SD unless indicated

Conclusion: Exposure to stress in ERA pts negatively affects PROs. Given that patient self report of stress may be affected by recall bias and attribution prospective studies on the prevalence and impact of stress in early inflammatory arthritis are needed. Stress may be a significant contextual factor to consider when assessing PROs in long term observational studies of RA.


Disclosure:

Y. A. Kim,
None;

J. E. Salmon,
None;

J. Xiong,
None;

B. Haraoui,
None;

C. A. Hitchon,
None;

E. Keystone,
None;

J. E. Pope,
None;

D. Tin,
None;

J. C. Thorne,
None;

G. Boire,
None;

V. P. Bykerk,

Amgen, Pfizer, Roche, BMS, UCB, Janssen Biotech and Abbott,

2;

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/effects-of-stress-on-clinical-presentation-of-patients-with-early-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology